Clinical Trials of Cancer
A section of Cancers (ISSN 2072-6694).
Section Information
Cancers seeks to publish interesting articles reporting results of early or late phase clinical trials on any topic connected with clinical oncology. Topics include, but are not limited to, the following:
- Breast cancer
- Developmental therapeutics
- Endocrine system cancer
- Gastrointestinal cancer
- Genitourinary cancer
- Gynecological cancer
- Hematological cancer
- Head and neck cancer
- Neurooncology
- Pediatric oncology
- Thoracic oncology
- Sarcoma
- Skin cancer
- Epidemiology, cancer prevention, and cancer control
- Supportive care
- Imaging
- Health care systems
We invite submission of all clinical trials, whether phase 1, 2, 3, or 4. For phase 1 trials, we especially encourage those that investigate a novel substance for a novel indication, a strong or unexpected beneficial or adverse response, or a novel mechanism of action.
We require registration of all interventional trials, whether early or late phase, in a primary register that participates in the WHO International Clinical Trial Registry Platform or in ClinicalTrials.gov, in accordance with the International Committee of Medical Journal Editors (ICMJE) recommendations.
Reports of trials must conform to the Consolidated Standards of Reporting Trials (CONSORT) 2010 guidelines and be submitted with a full protocol in English or with the full protocol and a synopsis in English that includes details of enrolment criteria, outcomes/endpoints, and statistical considerations.
All reports of randomized trials should include a section entitled “Randomization and Masking” within the Methods Section.Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Clinical Perspective and Translational Oncology of Liquid Biopsy (Deadline: 20 July 2022)
- Innovating for Transformative Change in Brain Tumour Discovery and Clinical Sciences (Deadline: 30 August 2022)
- Advances in Thyroid Cancer (Deadline: 31 August 2022)
- Updates on Breast Cancer (Deadline: 10 September 2022)
- Clinical and Physical Innovations in Magnetic-Resonance Guided Radiotherapy (Deadline: 15 September 2022)
- The Application of DNA Methylation in Cancers (Deadline: 15 October 2022)
- Pre-clinical Models in Glioblastoma (Deadline: 31 October 2022)
- Clinical Studies in Peritoneal Surface Malignancies (Deadline: 1 November 2022)
- Updates on the Treatment of Gastroesophageal Cancer (Deadline: 15 November 2022)
- Advances in Radiotherapy and Prognosis of Rectal Cancer (Deadline: 20 November 2022)
- Diagnostic, Prognostic, Predictive Biomarkers and New Targets for Treatment in Head and Neck Cancers (Deadline: 30 November 2022)
- Diagnostic and Treatment for Three Urological Cancers: Bladder Cancer, Kidney Cancer and Prostate Cancer (Deadline: 20 December 2022)
- Latest Development in B Cell Malignancies (Deadline: 31 January 2023)
- Clinical Studies and Outcomes in Gynecological Cancers (Deadline: 1 February 2023)
- Innovative Cancer Treatments and Photodynamic Therapy (Deadline: 5 February 2023)
- New Insights into Clinical and Translational Research in Nasopharyngeal Carcinoma (Deadline: 28 February 2023)
- Clinical PET Studies in Neuro-Oncology (Deadline: 1 March 2023)
- Novel Metabolic Approaches Targeting Cancer Cells (Deadline: 31 March 2023)
- Two Years into the COVID-19 Pandemic: What It Means for Our Cancer Patients (Deadline: 30 April 2023)
Topical Collection
Following topical collection within this section is currently open for submissions:
